Federal officials have announced a significant policy change regarding medical cannabis regulations. The acting attorney general has released a memorandum detailing plans to reclassify medical marijuana products, moving them away from the most stringent regulatory tier.
This policy adjustment represents a shift in the federal government’s approach to cannabis-based medical treatments, potentially making these products more accessible to patients and healthcare providers.
